<DOC>
	<DOCNO>NCT02113696</DOCNO>
	<brief_summary>Ingestion capsule omega 3 EPA DHA , 1.8 g EPA 1.2 g DHA morbidly obese patient , improve inflammatory status ? C-reactive protein ? Weight ?</brief_summary>
	<brief_title>Intake Omega 3 Morbidly Obese Patients</brief_title>
	<detailed_description>Intake EPA DHA management morbid obesity capsule - Reduction inflammatory factor adipokines , glucose , C-reactive protein , cholesterol , weight , BMI . Will 2 group : case control . The case intake omega 3 capsule placebo control .</detailed_description>
	<mesh_term>Obesity , Morbid</mesh_term>
	<criteria>Men woman age 1865 year , BMI &gt; 40 kg/m2 ( &gt; 35 kg/m2 comorbidities ) , ambulatory , receive oral diet , diagnosis metabolic syndrome , sign Term Free Informed Consent . Systemic inflammatory response syndrome , coma compromise organ , fever infection focus , cancer without chemotherapy radiotherapy , radiotherapy , inflammatory disease gastrointestinal tract , transplant , trauma , surgery hospital stay past 30 day use steroids nonsteroid antiinflammatory immunomodulators agent antibiotic , refuse take part study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>morbid obesity</keyword>
	<keyword>BMI 4O kg/m2</keyword>
	<keyword>ingestion omega 3</keyword>
	<keyword>inflammatory cytokine</keyword>
	<keyword>biochemical factor</keyword>
	<keyword>anthropometric factor</keyword>
</DOC>